11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects-Reference-Cited by-同舟云学术

11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects

Published:2013-06-03 Issue:7 Volume:123 Page:3051-3060
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Tiganescu Ana,Tahrani Abd A.,Morgan Stuart A.,Otranto Marcela,Desmoulière Alexis,Abrahams Lianne,Hassan-Smith Zaki,Walker Elizabeth A.,Rabbitt Elizabeth H.,Cooper Mark S.,Amrein Kurt,Lavery Gareth G.,Stewart Paul M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference59 articles.

1. Cushing's syndrome

2. Different Skin Thinning Potential of Equipotent Medium-Strength Glucocorticoids

3. Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of 11 β-Hydroxysteroid Dehydrogenase Type I Activity in Patients With Psoriasis Vulgaris: A Novel Insight Into the Pathogenesis of the Disease;Cureus;2024-08-06

2. 11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent;2024-05-10

3. A 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, 11b-0048, effectively suppresses the expression of 11β-HSD1 activated in cultured keratinocytes and in diabetic murine skin;2024-01-12

4. 5α‐Tetrahydrocorticosterone: A topical anti‐inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis;British Journal of Pharmacology;2023-12-28

5. Role of corticosteroids in skin physiology and therapeutic potential of an 11β‐HSD1 inhibitor: A review;International Journal of Dermatology;2023-12-25